Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A decision-support system for hematology].

L Straka1, P Stránský, M Kmonícek

  • 1Katedra lékarské biofyziky, Lékarská fakulta Univerzity Karlovy, Hradec Králové, Czech Republic.

Sbornik Lekarsky
|May 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.

Physiological research·2023
Same author

Re: Letter to the Editor of Public Health in response to 'Links between alcohol and external causes of deaths in males: an autopsy study'.

Public health·2022
Same author

Links between alcohol and external causes of deaths in males: an autopsy study.

Public health·2022
Same author

Hysteretic structural changes within five-layered modulated 10M martensite of Ni-Mn-Ga(-Fe).

Journal of physics. Condensed matter : an Institute of Physics journal·2021
Same author

Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis.

Neoplasma·2020
Same author

Low temperature a/b nanotwins in Ni<sub>50</sub>Mn<sub>25+x</sub>Ga<sub>25-x</sub> Heusler alloys.

Scientific reports·2018
Same journal

[Tenth memorial of professor Frantisek Pór, MD].

Sbornik lekarsky·2004
Same journal

[The 150th birthday anniversary of Joseph Thomayer].

Sbornik lekarsky·2004
Same journal

[A brief overview of the history of the Institute of Human Studies in Medicine at the First Medical Faculty of Charles University in Prague].

Sbornik lekarsky·2004
Same journal

[The strategy and contemporary subjects of research in psychotherapy].

Sbornik lekarsky·2004
Same journal

[General psychotherapy].

Sbornik lekarsky·2004
Same journal

[Microsleep from the electro- and psychophysiological point of view].

Sbornik lekarsky·2004
See all related articles

Bleeding is a dangerous complication in hematological cancer treatment. This study identifies factors predicting bleeding risk, developing an application to aid clinical decisions on thrombocyte transfusions.

Area of Science:

  • Hematology
  • Oncology
  • Medical Informatics

Background:

  • Thrombocytopenia and subsequent bleeding are serious complications during hematological malignancy treatment.
  • Thrombocyte transfusions are crucial for preventing and managing bleeding, but their indication requires careful risk assessment.

Purpose of the Study:

  • To evaluate the risk of bleeding in patients undergoing treatment for hematological malignancies.
  • To identify factors that may increase the risk of bleeding.
  • To develop a practical tool for clinical use in assessing bleeding risk.

Main Methods:

  • Statistical analysis of patient data to identify potential bleeding risk factors.
  • Utilized the GUHA method and literature review for factor determination.
  • Trained three-layer neural networks using a non-linear backpropagation method for risk prediction.

Related Experiment Videos

Main Results:

  • Identified specific factors associated with an increased risk of bleeding.
  • Developed and trained a predictive model based on these factors.
  • Created a clinical application for routine bleeding risk assessment.

Conclusions:

  • Accurate bleeding risk assessment is critical for guiding thrombocyte transfusion decisions.
  • The developed application can assist clinicians in routine practice for better patient management.
  • Further refinement of risk prediction models can improve patient outcomes in hematological malignancies.